CTLs target Th cells that acquire bystander MHC class I-peptide complex from APCs

Area of Science:

• Immunology
• Cellular Biology
• T cell interactions

Background:

• T cells can acquire peptide-MHC complexes from other cells.
• The purpose of this acquisition and its impact on immune responses remain incompletely understood.
• Cytotoxic T lymphocytes (CTLs) recognize MHC class I-peptide complexes, while CD4(+) T cells interact with MHC class II-peptide complexes presented by antigen-presenting cells (APCs).

Purpose of the Study:

• To investigate whether human CD4(+) T helper (Th) cells can acquire MHC complexes from APCs.
• To determine if acquired MHC complexes render CD4(+) Th cells susceptible to CTL-mediated killing.
• To explore the implications of this interaction for immune regulation and pathology.

Main Methods:

• Studying the formation of the immunological synapse between human CD4(+) Th cells and APCs.
• Analyzing the transfer of membrane fragments and associated MHC class I and II peptide complexes.
• Assessing the susceptibility of CD4(+) Th cells to antigen-specific CTL killing after fragment acquisition.

Main Results:

• Human CD4(+) Th cells capture membrane fragments from APCs during immunological synapse formation.
• These captured fragments contain both MHC class II-peptide and MHC class I-peptide complexes.
• Acquisition of MHC class I-peptide complexes renders CD4(+) Th cells targets for antigen-specific CTL killing.

Conclusions:

• CD4(+) Th cells can acquire MHC class I-peptide complexes from APCs, making them susceptible to CTL-mediated lysis.
• This mechanism may represent a novel way to regulate CD4(+) T cell expansion in immune responses.
• Dysregulation of this process could contribute to immunopathology, particularly in viral infections like HIV.